Aaron Wealth Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Aaron Wealth Advisors's EW Position: Q2 2026 in Review
Aaron Wealth Advisors increased its Edwards Lifesciences (EW) stake by 7.3% in Q2 2026, buying an estimated $57.3K and bringing the position to 10,058 shares worth $910K. The position accounts for 0.05% of the portfolio, ranked #268.
Aaron Wealth Advisors first reported a position in EW in Q3 2021 and has held it in 15 quarters since. The position peaked at $2.24M in Q1 2022. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Aaron Wealth Advisors held 10,058 shares of Edwards Lifesciences worth $910K as of Q2 2026.
- Aaron Wealth Advisors bought 684 Edwards Lifesciences shares in Q2 2026, an estimated $57.3K.
- Edwards Lifesciences made up 0.05% of Aaron Wealth Advisors's portfolio in Q2 2026, its #268 holding.
- Aaron Wealth Advisors first reported a position in Edwards Lifesciences in Q3 2021 and has held it in 15 quarters since.
- Aaron Wealth Advisors's Edwards Lifesciences position peaked at $2.24M in Q1 2022.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.